Health effects of trans-fatty acids: experimental and observational evidence
The DOI matches its Crossref record; 89 of the 90 references it cites were found in a registry or an index.
Abstract
Background/objectives Growing evidence indicates that trans-fatty acids (TFA) adversely affect cardiovascular health. As part of the World Health Organization (WHO) Scientific Update on TFA, we reviewed the evidence for effects of TFA consumption on coronary heart disease (CHD).Subjects/methods We searched Medline publications examining TFA consumption and CHD risk factors or outcomes, emphasizing results of studies in humans. We evaluated and synthesized evidence from both controlled feeding trials evaluating risk factors and long-term observational studies evaluating risk factors or clinical outcomes, each of which have complementary strengths and limitations, to enable the most robust and reliable inferences of effects.Results The effects of TFA consumption on risk factors most consistently seen in both controlled trials and observational studies included adverse lipid effects (for example [upward arrow] low-density lipoprotein cholesterol, [downward arrow] high-density lipoprotein cholesterol (HDL-C), [upward arrow] total/HDL-C ratio), proinflammatory effects (for example [upward arrow] tumor necrosis factor-alpha activity, [upward arrow] interleukin-6, [upward arrow] C-reactive protein) and endothelial dysfunction. These effects were most prominent in comparison with cis unsaturated fats; adverse effects on total/HDL-C and endothelial function were also seen in comparison with saturated fatty acids (SFA). TFA may also worsen insulin sensitivity, particularly among individuals predisposed to insulin resistance; possible effects on weight gain and diabetes incidence require further confirmation. Five retrospective case-control studies and four prospective cohort studies demonstrated positive associations between TFA consumption and CHD events. A meta-analysis of prospective studies indicated 24, 20, 27 and 32% higher risk of myocardial infarction (MI) or CHD death for every 2% energy of TFA consumption isocalorically replacing carbohydrate, SFA, cis monounsaturated fatty acids and cis polyunsaturated fatty acids, respectively. The differential effects of specific TFA isomers may be important but are less well established. The available evidence indicates that trans-18:1 and particularly trans-18:2 isomers have stronger CHD effects than trans-16:1 isomers. The limited data suggest that the experimental effects of ruminant and industrial TFA are similar when consumed in similar quantities, but very few persons consume such high levels of ruminant TFA, and observational studies do not support adverse CHD effects of ruminant TFA in amounts actually consumed.Conclusions Controlled trials and observational studies provide concordant evidence that consumption of TFA from partially hydrogenated oils adversely affects multiple cardiovascular risk factors and contributes significantly to increased risk of CHD events. The public health implications of ruminant TFA consumption appear much more limited. The effects of specific TFA isomers require further investigation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Quantitatively, dietary trans fatty acids have a similar raising effect on LDL-C to that of SFAs.64”
From ESC/EAS Guidelines for the management of dyslipidaemias (2011) · cites this paper as [64]
In the citing paper
“While small amounts of “natural” TFA are found in meats and milk of ruminants (e.g., cow, sheep, goat; formed by gut microorganisms), these contribute minimally to diet (<0.5%E) and do not associate with CVD risk;375 indeed, trans-16:1n-7, a trace TFA biomarker of dairy fat, is linked to lower risk of diabetes and sudden death.247”
From Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review (2016) · cites this paper as [375]
Citations
Cites
Food, nutrition, physical activity, and the prevention of cancer: a global perspective
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,350 · cited 2×
“…relationships between TFA consumption and cancer incidence, and significant associations have generally not been observed (World Cancer Research Fund, 2007), although in the 20-year follow-up of the Nurses' Health Study, TFA intake during the premenopausal years was associated with incidence…”
BackgroundSelf-citationDiet, lifestyle, and the risk of type 2 diabetes mellitus in women.
Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz, G., Liu, S., Solomon, C. G., & Willett, W. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010492 · Cited by 2,901
Self-citationMensink, R. P., Zock, P. L., Kester, A. D., & Katan, M. B. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1146 · Cited by 2,811 · cited 5×
“In one metaanalysis of controlled trials (Mensink et al., 2003), the estimates of TFA effects on serum lipoproteins were based on calculations of changes in 18:1 TFA intake, the predominant isomer in partially hydrogenated vegetable oils.”
BackgroundMethodInfluentialDietary Fat Intake and the Risk of Coronary Heart Disease in Women
Hu, F. B., Stampfer, M. J., Manson, J. E., Rimm, E., Colditz, G. A., Rosner, B. A., Hennekens, C. H., & Willett, W. C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711203372102 · Cited by 1,782
Self-citationTrans fatty acids and cardiovascular disease
Mozaffarian, D., Katan, M. B., Ascherio, A., Stampfer, M. J., & Willett, W. C. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054035 · Cited by 1,752 · cited 9×
“…BMI, aspirin use, history of hypertension or hypercholesterolemia, alcohol use, and consumption of dietary SFA, nÀ3 PUFA, nÀ6 PUFA, MUFA, protein, fiber and total energy, the multivariable RR associated with a 2%E increment in TFA intake was 1.26 (95% CI ¼ 0.98–1.60) (Mozaffarian et al., 2006).”
BackgroundMethodInfluentialSelf-citationMensink, R. P., & Katan, M. B. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008163230703 · Cited by 1,424 · cited 3×
“three trials (Mensink and Katan, 1990; Zock and Katan, 1992; Aro et al. 1997), partially hydrogenated high-oleic-acid sunflower oil (not often used in commercially available food products) was the main source of TFA, in which 18:1 n 9 (D9) elaidic acid was the most common TFA isomer.”
BackgroundInfluentialIntake of trans fatty acids and risk of coronary heart disease among women
WILLETT, W. (1993) · The Lancet · doi:10.1016/0140-6736(93)90350-p · Cited by 1,025 · cited 6×
“In the first report on TFA from the Nurses’ Health Study (Willett et al., 1993), when total intake of TFA was partitioned into industrial and ruminant sources, the positive association with CHD risk was entirely explained by industrial TFA.”
BackgroundInfluentialSelf-citationDietary fat intake and risk of type 2 diabetes in women
Salmerón, J., Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz, G. A., Rimm, E. B., & Willett, W. C. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.6.1019 · Cited by 818 · cited 4×
“overweight or obese or who had lower levels of physical activity (Salmeron et al., 2001).”
BackgroundInfluentialSelf-citationDietary Patterns and Risk for Type 2 Diabetes Mellitus in U.S. Men
van Dam, R. M., Rimm, E. B., Willett, W. C., Stampfer, M. J., & Hu, F. B. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-3-200202050-00008 · Cited by 801 · cited 2×
“As described above, the Iowa Women's Health Study (Meyer et al., 2001) and Health Professionals Follow-up Study (van Dam et al., 2002) detected no significant associations of TFA consumption with incidence of type II diabetes.”
BackgroundInfluentialSelf-citationDietary fat and risk of coronary heart disease in men: cohort follow up study in the United States
Ascherio, A., Rimm, E. B., Giovannucci, E. L., Spiegelman, D., Meir, S., & Willett, W. C. (1996) · BMJ · doi:10.1136/bmj.313.7049.84 · Cited by 739 · cited 2×
“In the first report from this study (Ascherio et al., 1996), 734 acute MI or CHD deaths were documented during 6 years of follow-up among Health effects of trans-fatty acids D Mozaffarian et al S13 European Journal of Clinical Nutrition 43 757 health professionals aged 40–75 years and free of…”
BackgroundSelf-citationLopez-Garcia, E., Schulze, M. B., Meigs, J. B., Manson, J. E., Rifai, N., Stampfer, M. J., Willett, W. C., & Hu, F. B. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.3.562 · Cited by 600 · cited 16×
“…of endothelial dysfunction, including endothelin-1, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1; in fact, the estimated dietary intake of trans-16:1 was associated with lower inflammatory and endothelial dysfunction markers in one study (Lopez-Garcia et al., 2005).”
BackgroundInfluentialSelf-citationPietinen, P., Ascherio, A., Korhonen, P., Hartman, A. M., Willett, W. C., Albanes, D., & Virtamo, J. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009047 · Cited by 557 · cited 3×
“The relation of intakes of specific dietary fats and risk of CHD was examined in a cohort of 21 930 Finnish men who were initially free of diagnosed cardiovascular disease and participating in a trial of beta-carotene and vitamin E (Pietinen et al., 1997).”
BackgroundInfluentialSelf-citationOh, K. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi085 · Cited by 499 · cited 4×
“, 2007), compared with estimated TFA intake from dietary questionnaires (Willett et al., 1993; Hu et al., 1997; Oh et al., 2005) in the same cohort, suggest that inaccuracies (random error) in dietary questionnaire estimation may significantly attenuate the true association with CHD risk and/or that TFA in cell membra…”
BackgroundMethodInfluentialOomen, C. M., Ocké, M. C., Feskens, E. J., Erp-Baart, M.-A. J. V., Kok, F. J., & Kromhout, D. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04166-0 · Cited by 491 · cited 3×
“In this prospective cohort study among 667 Dutch men (Oomen et al., 2001) , total TFA intake was associated with higher CHD risk.”
BackgroundInfluentialBaer, D. J., Judd, J. T., Clevidence, B. A., & Tracy, R. P. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.6.969 · Cited by 476 · cited 3×
“…healthy men, five weeks of TFA consumption (8%E) increased levels of E-selectin, a circulating biomarker of endothelial dysfunction, by 10, 14, 6 and 6% compared with equivalent calories from carbohydrate, MUFA, stearic acid or shorter-chain (12:0–16:0) SFA, respectively (Baer et al., 2004).”
BackgroundInfluentialDietarytrans fatty acids: effects on plasma lipids and lipoproteins of healthy men and women
Judd, J., Clevidence, B., Muesing, R., Wittes, J., Sunkin, M., & Podczasy, J. (1994) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/59.4.861 · Cited by 457 · cited 1×
“Partially hydrogenated soybean oil was used in three other trials (Almendingen et al., 1995; Muller et al., 1998a; Lichtenstein et al., 1999), and in four trials the source of TFA was not specified (Judd et al., 1994, 1998, 2002; Lovejoy et al., 2002).”
MethodDietary intake of trans fatty acids and systemic inflammation in women
Mozaffarian, D., Pischon, T., Hankinson, S. E., Rifai, N., Joshipura, K., Willett, W. C., & Rimm, E. B. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.4.606 · Cited by 447 · cited 16×
“In a crosssectional study of 730 mostly overweight women (mean BMI ¼ 26.3 kg/m”
BackgroundMethodInfluentialSelf-citationZock, P., & Katan, M. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41530-5 · Cited by 440
Mozaffarian, D., & Clarke, R. (2009) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602976 · Cited by 410 · cited 16×
“Reducing TFA intake by 2%E, corresponding to the estimated average intake of industrial TFA in the USA in 1990, and replacing with a 1:1 mix of MUFA and PUFA, would reduce the total/HDL-C ratio by 0.11.”
BackgroundMethodInfluentialSelf-citationKoh-Banerjee, P., Chu, N.-F., Spiegelman, D., Rosner, B., Colditz, G., Willett, W., & Rimm, E. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.4.719 · Cited by 383 · cited 1×
“001) after adjustment for measurement error and other risk factors (Koh-Banerjee et al., 2003).”
BackgroundSelf-citationDietary fat and incidence of type 2 diabetes in older Iowa women
Meyer, K. A., Kushi, L. H., Jacobs, D. R., & Folsom, A. R. (2001) · Diabetes Care · doi:10.2337/diacare.24.9.1528 · Cited by 382 · cited 5×
“…this study, the diagnosis of diabetes was based on self-report and was found to be incorrect in more than one-third of cases in a validation study (Meyer et al., 2001), and diet was assessed only at baseline and may have changed over time; thus, misclassification of both exposure and outcome may…”
BackgroundMethodInfluentialTrans-fatty acids intake and risk of myocardial infarction.
Ascherio, A., Hennekens, C. H., Buring, J. E., Master, C., Stampfer, M. J., & Willett, W. C. (1994) · Circulation · doi:10.1161/01.cir.89.1.94 · Cited by 373 · cited 2×
“This case–control study of nonfatal MI in six hospitals in the Boston area included 239 cases and 282 population controls (Ascherio et al., 1994).”
BackgroundSelf-citationEffects of Different Forms of Dietary Hydrogenated Fats on Serum Lipoprotein Cholesterol Levels
Lichtenstein, A. H., Ausman, L. M., Jalbert, S. M., & Schaefer, E. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906243402501 · Cited by 352 · cited 4×
“In one trial (Lichtenstein et al., 1999) comparing different levels of TFA (from 0.”
BackgroundMethodInfluentialEffect of dietary cis and trans fatty acids on serum lipoprotein[a] levels in humans.
Mensink, R., Zock, P., Katan, M., & Hornstra, G. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41404-x · Cited by 329
Risérus, U., Basu, S., Jovinge, S., Fredrikson, G. N., Ärnlöv, J., & Vessby, B. (2002) · Circulation · doi:10.1161/01.cir.0000033589.15413.48 · Cited by 292 · cited 1×
“…et al. (2004) found that a chemically produced blend of CLA isomers increased serum HDL-C and reduced the LDL:HDL-C ratio in 32 patients with type II diabetes, but it also impaired blood glucose control and reduced insulin sensitivity in accordance with other studies (Riserus et al., 2002, 2004).”
ResultTrans Fatty Acids and Their Effects on Lipoproteins in Humans
Katan, M. B., Zock, P. L., & Mensink, R. P. (1995) · Annual Review of Nutrition · doi:10.1146/annurev.nu.15.070195.002353 · Cited by 287 · cited 2×
“Interestingly, other dietary factors (including other dietary fats) are not wellknown to affect Lp(a) levels; nevertheless, the effect of TFA of Lp(a) may be modest compared with estimated genetic influences (Katan et al., 1995).”
BackgroundAro, A., Jauhiainen, M., Partanen, R., Salminen, I., & Mutanen, M. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1419 · Cited by 281 · cited 4×
“three trials (Mensink and Katan, 1990; Zock and Katan, 1992; Aro et al. 1997), partially hydrogenated high-oleic-acid sunflower oil (not often used in commercially available food products) was the main source of TFA, in which 18:1 n 9 (D9) elaidic acid was the most common TFA isomer.”
BackgroundInfluentialSelf-citationDietary Fat and Weight Gain Among Women in the Nurses’ Health Study
Field, A. E., Willett, W. C., Lissner, L., & Colditz, G. A. (2007) · Obesity · doi:10.1038/oby.2007.616 · Cited by 278 · cited 1×
“In a second study among more than 41 000 women who provided two measurements of weight over 8 years, increases in TFA consumption were robustly associated with increases in body weight in both cross-sectional and longitudinal analyses, after adjustment for other risk factors (Field et al., 2007).”
BackgroundSelf-citationEstimated Intakes of Trans Fatty and Other Fatty Acids in the US Population
ALLISON, D. B., EGAN, S. K., BARRAJ, L. M., CAUGHMAN, C., INFANTE, M., & HEIMBACH, J. T. (1999) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(99)00041-3 · Cited by 271 · cited 2×
“By the early 1990s, TFA consumption was approximately 2.6%E in the US (about 7.4% of all dietary fat) (Allison et al., 1999).”
BackgroundInfluentialHan, S. N., Leka, L. S., Lichtenstein, A. H., Ausman, L. M., Schaefer, E. J., & Meydani, S. N. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30151-6 · Cited by 263
Chardigny, J.-M., Destaillats, F., Malpuech-Brugère, C., Moulin, J., Bauman, D. E., Lock, A. L., Barbano, D. M., Mensink, R. P., Bezelgues, J.-B., Chaumont, P., et al. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.3.558 · Cited by 252 · cited 1×
“Health effects of trans-fatty acids D Mozaffarian et al S16 European Journal of Clinical Nutrition Recently, TFA (5%E) from modified milk fat versus partially hydrogenated vegetable oil were compared in a crossover study of 46 healthy subjects (Chardigny et al., 2008).”
BackgroundAbbey, M., Noakes, M., Belling, G., & Nestel, P. (1994) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/59.5.995 · Cited by 251 · cited 1×
“Effects on both production and metabolism of lipoproteins appear to occur; an increase in the activity of cholesterol ester transfer protein (Abbey et al., 1994; van Tol et al., 1995) may also contribute to a rise in LDL-C and a reduction in HDL-C with TFA consumption.”
BackgroundMoloney, F., Yeow, T.-P., Mullen, A., Nolan, J. J., & Roche, H. M. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.4.887 · Cited by 247 · cited 2×
“Moloney et al. (2004) found that a chemically produced”
ResultA Prospective Study of Trans Fatty Acids in Erythrocytes and Risk of Coronary Heart Disease
Sun, Q., Ma, J., Campos, H., Hankinson, S. E., Manson, J. E., Stampfer, M. J., Rexrode, K. M., Willett, W. C., & Hu, F. B. (2007) · Circulation · doi:10.1161/circulationaha.106.679985 · Cited by 246 · cited 5×
“The stronger results using measured TFA levels (Sun et al., 2007), compared with estimated TFA intake from dietary questionnaires (Willett et al.”
BackgroundMethodInfluentialSelf-citationLovejoy, J. C., Smith, S. R., Champagne, C. M., Most, M. M., Lefevre, M., DeLany, J. P., Denkins, Y. M., Rood, J. C., Veldhuis, J., & Bray, G. A. (2002) · Diabetes Care · doi:10.2337/diacare.25.8.1283 · Cited by 246 · cited 3×
“, 1999), and in four trials the source of TFA was not specified (Judd et al., 1994, 1998, 2002; Lovejoy et al., 2002).”
BackgroundMethodKROMHOUT, D., FESKENS, E. J. M., & BOWLES, C. H. (1995) · International Journal of Epidemiology · doi:10.1093/ije/24.2.340 · Cited by 246 · cited 2×
“In 1987 and 1988, equivalent food composites representing the average food intake of each cohort at baseline were collected locally and analyzed in a central laboratory (Kromhout et al., 1995).”
BackgroundRisérus, U., Vessby, B., Ärnlöv, J., & Basu, S. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.2.279 · Cited by 243 · cited 1×
“…et al. (2004) found that a chemically produced blend of CLA isomers increased serum HDL-C and reduced the LDL:HDL-C ratio in 32 patients with type II diabetes, but it also impaired blood glucose control and reduced insulin sensitivity in accordance with other studies (Riserus et al., 2002, 2004).”
ResultDietary fat is not a major determinant of body fat
Willett, W. C., & Leibel, R. L. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00992-5 · Cited by 241 · cited 2×
“In both of these studies, changes in consumption of other fats, including total fat, SFA, MUFA and PUFA, were much less strongly associated with adiposity/weight gain, consistent with prior findings that neither total dietary fat nor most fat subtypes are major determinants of body fat or weight gain (Willett and Leib…”
ResultSelf-citationCell Membrane Trans -Fatty Acids and the Risk of Primary Cardiac Arrest
Lemaitre, R. N., King, I. B., Raghunathan, T. E., Pearce, R. M., Weinmann, S., Knopp, R. H., Copass, M. K., Cobb, L. A., & Siscovick, D. S. (2002) · Circulation · doi:10.1161/hc0602.103583 · Cited by 220 · cited 1×
“In this population-based case– control study (Lemaitre et al., 2002), 179 cases of out-ofhospital cardiac arrest (sudden death) were matched to 285 community controls.”
MethodTrans Fat Diet Induces Abdominal Obesity and Changes in Insulin Sensitivity in Monkeys
Kavanagh, K., Jones, K. L., Sawyer, J., Kelley, K., Carr, J. J., Wagner, J. D., & Rudel, L. L. (2007) · Obesity · doi:10.1038/oby.2007.200 · Cited by 208 · cited 2×
“Perhaps most relevant to humans, a 6-year randomized controlled trial in nonhuman primates evaluated diets containing 8%E from either TFA or MUFA (Kavanagh et al., 2007).”
BackgroundMethodAro, A., Salminen, I., Huttunen, J. K., Kardinaal, A. F. M., van't Veer, P., Kark, J. D., Riemersma, R. A., Delgado-Rodriguez, M., Gomez-Aracena, J., Kohlmeier, L., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90273-2 · Cited by 207 · cited 2×
“In this international multicenter study in eight European countries and Israel, trans-18:1 n 9 levels (but not other TFA isomers or total TFA) were measured in adipose tissue samples obtained from 671 men with acute nonfatal MI in 1991–1992 and 717 men without a history of MI (controls) (Aro et al., 1995).”
MethodSelf-citationDietary fatty acid intakes and the risk of ovulatory infertility
Chavarro, J. E., Rich-Edwards, J. W., Rosner, B. A., & Willett, W. C. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.1.231 · Cited by 203 · cited 2×
“Higher TFA intake has been associated with incidence of cholelithiasis (Tsai et al., 2005) and anovulatory infertility (Chavarro et al., 2007), both conditions associated with insulin resistance.”
BackgroundSelf-citationde Roos, N. M., Bots, M. L., & Katan, M. B. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0701.092161 · Cited by 198 · cited 1×
“A longer duration (4 weeks) of TFA intake (9.2%E) significantly lowered HDL-C (21% reduction) and impaired brachial artery flow-mediated vasodilatation (29% reduction) compared with equivalent calories from SFA (de Roos et al., 2001).”
BackgroundInfluentialHe, K., Merchant, A., Rimm, E. B., Rosner, B. A., Stampfer, M. J., Willett, W. C., & Ascherio, A. (2003) · BMJ · doi:10.1136/bmj.327.7418.777 · Cited by 195 · cited 1×
“However, in a prospective study of male health professionals (He et al., 2003), TFA intake was not significantly associated with incidence of clinical stroke.”
BackgroundSelf-citationtrans Fatty acids and systemic inflammation in heart failure
Mozaffarian, D., Rimm, E. B., King, I. B., Lawler, R. L., McDonald, G. B., & Levy, W. C. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1521 · Cited by 190 · cited 15×
“In a crosssectional study of 730 mostly overweight women (mean BMI ¼ 26.3 kg/m”
BackgroundMethodInfluentialSelf-citationChristiansen, E., Schnider, S., Palmvig, B., Tauber-Lassen, E., & Pedersen, O. (1997) · Diabetes Care · doi:10.2337/diacare.20.5.881 · Cited by 175 · cited 2×
“Among 16 obese subjects with type II diabetes (Christiansen et al., 1997), diets with 30%E total fat, including either 20%E from SFA, MUFA or TFA, were provided for 6 weeks in a randomized crossover design.”
BackgroundMethodLemaitre, R. N., King, I. B., Mozaffarian, D., Sotoodehnia, N., Rea, T. D., Kuller, L. H., Tracy, R. P., & Siscovick, D. S. (2006) · Circulation · doi:10.1161/circulationaha.106.620336 · Cited by 175 · cited 1×
“This prospective nested case– control study (Lemaitre et al., 2006) was performed in a population-based study of older US adults.”
MethodSelf-citationAlmendingen, K., Jordal, O., Kierulf, P., Sandstad, B., & Pedersen, J. I. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41144-7 · Cited by 173
Approaches to removing trans fats from the food supply in industrialized and developing countries
L'Abbé, M. R., Stender, S., Skeaff, C. M., Ghafoorunissa, & Tavella, M. (2009) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2009.14 · Cited by 169 · cited 2×
“Indeed, as reviewed elsewhere in this Supplement (L'Abbé et al., 2009) , experiences in Denmark, the Netherlands and New York City indicate that it is possible to largely eliminate industrial TFA in foods.”
Tricon, S., Burdge, G. C., Jones, E. L., Russell, J. J., El-Khazen, S., Moretti, E., Hall, W. L., Gerry, A. B., Leake, D. S., Grimble, R. F., et al. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.4.744 · Cited by 165 · cited 1×
“Tricon et al. (2006) evaluated, in 32 healthy men, the effects of 6 weeks of dairy products enriched with vaccenic acid and CLA (produced by feeding cows a mixture of fish oil and sunflower oil), supplying 2.1%E trans-18:1, mostly (75”
BackgroundInfluentialIntake of ruminant trans fatty acids and risk of coronary heart disease
Jakobsen, M. U., Overvad, K., Dyerberg, J., & Heitmann, B. L. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dym243 · Cited by 164 · cited 3×
“Indeed, as reviewed elsewhere in this Supplement (L'Abbé et al., 2009) , experiences in Denmark, the Netherlands and New York City indicate that it is possible to largely eliminate industrial TFA in foods.”
BackgroundInfluentialLichtenstein, A. H., Erkkilä, A. T., Lamarche, B., Schwab, U. S., Jalbert, S. M., & Ausman, L. M. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.07.005 · Cited by 163 · cited 3×
“Among 36 volunteers with hypercholesterolemia, C-reactive protein (CRP) levels were not significantly different following 5 weeks of different diets providing 20%E from different fats and oils with variable amounts of TFA (Lichtenstein et al., 2003).”
BackgroundMortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison
Neubauer, S., Welte, R., Beiche, A., Koenig, H.-H., Buesch, K., & Leidl, R. (2006) · Tobacco Control · doi:10.1136/tc.2006.016030 · Cited by 162 · cited 1×
“While this increase in TFA consumption correlated with increased rates of MI (Neubauer et al., 2006), the many other changes in diet and lifestyle that occurred during this period preclude conclusions from these time-trends regarding the specific effects of TFA.”
BackgroundEffect of different forms of dietary hydrogenated fats on LDL particle size
Mauger, J.-F., Lichtenstein, A. H., Ausman, L. M., Jalbert, S. M., Jauhiainen, M., Ehnholm, C., & Lamarche, B. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.3.370 · Cited by 161 · cited 2×
“In one trial (Mauger et al., 2003), the consumption of partially hydrogenated soybean oil in the form of semiliquid margarines containing 0.6–26/100 g of TFA decreased LDL particle size, a possible independent CHD risk factor, in a dose-dependent manner.”
BackgroundInfluentialVega-López, S., Ausman, L. M., Jalbert, S. M., Erkkilä, A. T., & Lichtenstein, A. H. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.1.54 · Cited by 160 · cited 1×
“Vega-Lopez et al. (2006) compared the effects of 20%E as palm, soybean, canola or partially hydrogenated soybean oil (4.2%E TFA) for 5 weeks each in 15 moderately hyperlipidemic subjects (mean BMI 26.0 kg/m”
BackgroundInfluentialTrans isomers of oleic and linoleic acids in adipose tissue and sudden cardiac death
Roberts, T. L., Wood, D. A., Riemersma, R. A., Gallagher, P. J., & Lampe, F. C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90274-0 · Cited by 154 · cited 2×
“Adipose TFA levels, including levels of trans-18:1 and trans-18:2 (but not trans- 16:1), were measured in 66 cases of sudden cardiac death and 286 healthy controls (Roberts et al., 1995).”
BackgroundTrans Fatty Acids in Adipose Tissue and the Food Supply Are Associated with Myocardial Infarction
Clifton, P. M., Keogh, J. B., & Noakes, M. (2004) · Journal of Nutrition · doi:10.1093/jn/134.4.874 · Cited by 134 · cited 2×
“In this Australian case–control study of first nonfatal MI (Clifton et al., 2004), TFA were”
BackgroundDietary cis and trans monounsaturated and saturated FA and plasma lipids and lipoproteins in men
Judd, J. T., Baer, D. J., Clevidence, B. A., Kris‐Etherton, P., Muesing, R. A., & Iwane, M. (2002) · Lipids · doi:10.1007/s11745-002-0871-9 · Cited by 132 · cited 1×
“Partially hydrogenated soybean oil was used in three other trials (Almendingen et al., 1995; Muller et al., 1998a; Lichtenstein et al., 1999), and in four trials the source of TFA was not specified (Judd et al., 1994, 1998, 2002; Lovejoy et al., 2002).”
MethodTholstrup, T., Raff, M., Basu, S., Nonboe, P., Sejrsen, K., & Straarup, E. M. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.237 · Cited by 128 · cited 3×
“In a second study (Tholstrup et al., 2006), 42 young healthy men were randomized to a 5-week diet with either control butter or butter higher in vaccenic acid (1.”
BackgroundInfluentialAdipose Tissue α-Linolenic Acid and Nonfatal Acute Myocardial Infarction in Costa Rica
Baylin, A., Kabagambe, E. K., Ascherio, A., Spiegelman, D., & Campos, H. (2003) · Circulation · doi:10.1161/01.cir.0000058165.81208.c6 · Cited by 121 · cited 5×
“In a population-based case– control study in Costa Rica (Baylin et al., 2003), 482 people with first nonfatal MI were matched with the same number of control participants.”
BackgroundInfluentialIbrahim, A., Natarajan, S., & Ghafoorunissa (2005) · Metabolism · doi:10.1016/j.metabol.2004.08.019 · Cited by 114 · cited 2×
“Ibrahim et al. (2005) demonstrated that rats fed a diet with”
BackgroundJudd, J. T., Baer, D. J., Clevidence, B. A., Muesing, R. A., Chen, S. C., Weststrate, J. A., Meijer, G. W., Janet, W., Lichtenstein, A. H., Vilella-Bach, M., et al. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.4.768 · Cited by 111 · cited 3×
“TFA consumption increased Lp(a) levels in six studies (Mensink et al., 1992; Almendingen et al., 1995; Aro et al., 1997; Clevidence et al., 1997; Judd et al., 1998; Lichtenstein et al., 2003) but not significantly in one study (Muller et al.”
BackgroundMethodDietary trans fatty acids increase serum cholesterylester transfer protein activity in man
van Tol, A., Zock, P. L., van Gent, T., Scheek, L. M., & Katan, M. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05509-h · Cited by 106 · cited 1×
“Effects on both production and metabolism of lipoproteins appear to occur; an increase in the activity of cholesterol ester transfer protein (Abbey et al., 1994; van Tol et al., 1995) may also contribute to a rise in LDL-C and a reduction in HDL-C with TFA consumption.”
BackgroundA high-trans fatty acid diet and insulin sensitivity in young healthy women
Louheranta, A. M., Turpeinen, A., Vidgren, H. M., Schwab, U., & Uusitupa, M. I. J. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90221-4 · Cited by 104 · cited 2×
“In contrast, Mutanen and Aro (1997) compared TFA with stearic acid and found similar effects on markers of coagulation and fibrinolysis, and Louheranta et al. (1999) reported similar effects on coagulation factors of TFA versus MUFA.”
BackgroundMethodInfluentialTrans fatty acids and cardiovascular risk: A unique cardiometabolic imprint?
Mozaffarian, D., & Willett, W. C. (2007) · Current Atherosclerosis Reports · doi:10.1007/s11883-007-0065-9 · Cited by 104 · cited 2×
“Together, these findings suggest that among dietary fats, TFA consumption produces a unique cardiometabolic imprint (Mozaffarian and Willett, 2007), aggravating multiple related pathways linked to the insulin resistance/metabolic syndrome .”
BackgroundSelf-citationLefevre, M., Lovejoy, J. C., Smith, S. R., DeLany, J. P., Champagne, C. M., Most, M. M., Denkins, Y. M., de Jonge, L., Rood, J. C., & Bray, G. A. (2005) · Metabolism · doi:10.1016/j.metabol.2005.06.015 · Cited by 98 · cited 1×
“Lefevre et al. (2005) evaluated the acute effects of two single 50%E fat meals, including 10%E from either TFA or MUFA, fed at 1-week intervals to 22 moderately overweight men and women who carried at least one copy of a fatty acid-binding protein-2 gene variant.”
MethodClevidence, B. A., Judd, J. T., Schaefer, E. J., Jenner, J. L., Lichtenstein, A. H., Muesing, R. A., Wittes, J., & Sunkin, M. E. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.9.1657 · Cited by 95 · cited 4×
“TFA consumption increased Lp(a) levels in six studies (Mensink et al., 1992; Almendingen et al., 1995; Aro et al., 1997; Clevidence et al., 1997; Judd et al., 1998; Lichtenstein et al., 2003) but not significantly in one study (Muller et al.”
BackgroundInfluentialHigh Dietary Fat Promotes Syndrome X in Nonobese Rats
Axen, K. V., Dikeakos, A., & Sclafani, A. J. (2003) · Journal of Nutrition · doi:10.1093/jn/133.7.2244 · Cited by 94 · cited 2×
“Axen et al. (2003)”
MethodDoney, A. S. F., Fischer, B., Leese, G., Morris, A. D., & Palmer, C. N. A. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000147897.57527.e4 · Cited by 93 · cited 1×
“TFA was associated with higher risk of dementia in one prospective study (Doney et al., 2004), suggestive of a potentially adverse effect on cerebrovascular disease.”
Backgroundde Roos, N., Siebelink, E., Bots, M. L., van Tol, A., Schouten, E., & Katan, M. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601377 · Cited by 57 · cited 1×
“Consumption of a single meal enriched with TFA or SFA showed similar acute adverse effects on postprandial flow-mediated vasodilatation of the brachial artery, a functional measure of endothelial health (de Roos et al., 2002).”
BackgroundEffect of dietary elaidic versus vaccenic acid on blood and liver lipids in the hamster
Meijer, G. W. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00661-4 · Cited by 56 · cited 1×
“In one study in hamsters (Meijer et al., 2001), the effects of elaidic acid (33%E), the main 18:1 trans-isomer in many partially hydrogenated vegetable oils versus vaccenic acid (33%E), the main TFA isomer in ruminant fat, were compared over 4 weeks.”
BackgroundTrans fatty acids induce apoptosis in human endothelial cells.
Zapolska‐Downar, D., Kośmider, A., & Naruszewicz, M. (2005) · PubMed · Cited by 52
Müller, H., Jordal, O., Kierulf, P., Kirkhus, B., & Pedersen, J. I. (1998) · Lipids · doi:10.1007/s11745-998-0284-9 · Cited by 52 · cited 4×
“Partially hydrogenated soybean oil was used in three other trials (Almendingen et al., 1995; Muller et al., 1998a; Lichtenstein et al., 1999), and in four trials the source of TFA was not specified (Judd et al.”
BackgroundMethodInfluentialVermunt, S. H. F., Beaufrère, B., Riemersma, R. A., Sébédio, J.-L., Chardigny, J.-M., & Mensink, R. P. (2001) · British Journal of Nutrition · doi:10.1079/bjn2000270 · Cited by 52 · cited 4×
“In one trial, TFA trienes (trans-18:3; 1.4 g/day) increased the LDL:HDL-C ratio (Vermunt et al., 2001), suggesting similar effects as trans-18:1 on serum lipoproteins.”
BackgroundMethodInfluentialKim, S. H., Chunawala, L., Linde, R. B., & Reaven, G. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.043 · Cited by 48 · cited 2×
“Few studies have evaluated relationships between TFA consumption and cancer incidence, and significant associations have generally not been observed (World Cancer Research Fund, 2007), although in the 20-year follow-up of the Nurses’ Health Study, TFA intake during the premenopausal years was associated with incidence…”
BackgroundAlmendingen, K., Seljeflot, I., Sandstad, B., & Pedersen, J. I. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.3.375 · Cited by 48 · cited 1×
“Almendingen et al. (1996) found an unfavorable antifibrinolytic effect of partially hydrogenated soybean oil compared with partially hydrogenated fish oil, and butter increased fibrinogen levels compared with partially hydrogenated fish oil.”
BackgroundThomas, L. H., Winter, J. A., & Scott, R. G. (1983) · Journal of Epidemiology and Community Health · doi:10.1136/jech.37.1.16 · Cited by 47 · cited 2×
“Tricon et al. (2006) evaluated, in 32 healthy men, the effects of 6 weeks of dairy products enriched with vaccenic acid and CLA (produced by feeding cows a mixture of fish oil and sunflower oil), supplying 2.”
BackgroundTholstrup, T., Sandström, B., Hermansen, J. E., & Hølmer, G. (1998) · Lipids · doi:10.1007/s11745-998-0175-0 · Cited by 45 · cited 2×
“Tholstrup et al. (1998) compared control dairy fat to dairy fat enriched (by changes in cow feed) with oleic acid, stearic acid and TFA (4.”
BackgroundInfluentialLong-term Intake of trans-Fatty Acids and Risk of Gallstone Disease in Men
Tsai, C.-J. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.9.1011 · Cited by 45 · cited 2×
“Higher TFA intake has been associated with incidence of cholelithiasis (Tsai et al., 2005) and anovulatory infertility (Chavarro et al.”
BackgroundMüller, H., Jordal, O., Seljeflot, I., Kierulf, P., Kirkhus, B., Ledsaak, O., & Pedersen, J. I. (1998) · British Journal of Nutrition · doi:10.1017/s0007114598001299 · Cited by 43 · cited 4×
“3%E SFA (Muller et al., 1998b).”
BackgroundMethodInfluentialMutanen, M., & Aro, A. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1655914 · Cited by 43 · cited 3×
“In contrast, Mutanen and Aro (1997) compared TFA with stearic acid and found similar effects on markers of coagulation and fibrinolysis, and Louheranta et al. (1999) reported similar effects on coagulation factors of TFA versus MUFA.”
BackgroundMethodSelf-citationCuchel, M., Schwab, U., Jones, P. J. H., Vogel, S., Lammi‐Keefe, C. J., Li, Z., Ordovás, J. M., McNamara, J. R., Schaefer, E. J., & Lichtenstein, A. H. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90061-x · Cited by 40 · cited 2×
“2%E from TFA did not significantly affect LDL particle size (Cuchel et al., 1996).”
BackgroundInfluentialColón‐Ramos, U., Baylín, A., & Campos, H. (2006) · Journal of Nutrition · doi:10.1093/jn/136.11.2887 · Cited by 35
Saravanan, N., Ibrahim, A., & Ghafoorunissa (2005) · British Journal Of Nutrition · doi:10.1079/bjn20051442 · Cited by 30 · cited 1×
“Natarajan et al. (2005) found that rats consuming 10%E TFA had decreased insulin-stimulated glucose transport compared with a diet with 10%E from SFA.”
MethodÅkesson, B., Johansson, B., Svensson, M., & Öckerman, P. A. (1981) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/34.11.2517 · Cited by 30 · cited 1×
“Similar intakes during this time were reported in the UK, Sweden and Germany (Akesson et al., 1981).”
ResultThomas, L. H., Winter, J. A., & Scott, R. G. (1983) · Journal of Epidemiology & Community Health · doi:10.1136/jech.37.1.22 · Cited by 28 · cited 1×
“This retrospective study measured post-mortem adipose TFA levels in 136 persons who had died from CHD and 95 persons who had died from other causes (Thomas et al., 1983a, b).”
BackgroundConsumption pattern of dietary fats in Chile: n-6 and n-3 fatty acids
Valenzuela, A., & Uauy, R. (1999) · International Journal of Food Sciences and Nutrition · doi:10.1080/096374899101328 · Cited by 26 · cited 2×
“, 2006), although this may not be the case in other regions of the world (Valenzuela and Uauy, 1999).”
BackgroundArmstrong, R. A., Chardigny, J., Beaufrère, B., Brétillon, L., Vermunt, S. H. F., Mensink, R. P., Macvean, A., Elton, R. A., Sébédio, J. L., & Riemersma, R. A. (2000) · Thrombosis Research · doi:10.1016/s0049-3848(00)00309-1 · Cited by 19 · cited 1×
“Armstrong et al. (2000) found no effects on platelet aggregation or blood coagulation by trans-isomers of a-linolenic acid.”
Background[Trans fatty acids in the Norwegian diet].
Johansson, L., Borgejordet, Å., & Pedersen, J. I. (2006) · PubMed · Cited by 17
Research works printed but not linked: 2
- European Food Safety Authority (2004). Opinion of the scientific panel on dietetic products, nutrition and allergies on a request from the Commission related to the presence of trans fatty acids in foods and the effect on human health of the consumption of trans fatty acids. EFSA J 81, 1–49.
- Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG et al. (2001b). Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345, 790–797. · DOI · Paper page
Cited by
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31828124ad · Cited by 5,292
Self-citationChronic inflammation in the etiology of disease across the life span
Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0675-0 · Cited by 4,915
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
ESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549
Metadata
- Authors
- Mozaffarian, D., Aro, A., & Willett, W. C.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Mozaffarian, D
- Venue
- European Journal of Clinical Nutrition
- Published
- 2009-05
- Volume
- 63
- Issue
- S2
- Pages
- S5-S21
- ISSN
- 0954-3007 (ISSN-L)
- 1476-5640
- OpenAlex
- W2118109560
- Cited by
- 662
- References
- 90
- Citations by year
- 2026: 9 · 2025: 24 · 2024: 27 · 2023: 40 · 2022: 32 · 2021: 37 · 2020: 40 · 2019: 48 · 2018: 29 · 2017: 46 · 2016: 51 · 2015: 58 · 2014: 45 · 2013: 42 · 2012: 50
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- European Journal of Clinical Nutrition (publishedVersion)
- PubMed (publishedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Funders
- National Institutes of Health (1k08hl075628-01)
- National Heart, Lung, and Blood Institute (K08-HL-075628)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- trans fatty acids, coronary artery disease, cardiovascular risk, LDL cholesterol, HDL cholesterol, inflammation, endothelial dysfunction, insulin sensitivity, insulin resistance, myocardial infarction, ruminant trans fatty acids, industrial trans fatty acids, dietary fat, dietary cholesterol, dietary fiber, dietary sodium, dietary calcium, dietary magnesium, potassium intake
- MeSH terms
- Animals, Coronary Disease, Dietary Fats, Endothelium, Vascular, Humans, Inflammation, Insulin Resistance, Isomerism, Myocardial Infarction, Risk Factors, Trans Fatty Acids, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.